Scheduler, Science

For 75 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform.

In return, we’ll help you build a career that you can feel passionate about.

We are seeking a Scheduler I (Technical Operations) for our Safety Assessment site located in Reno, Nevada.

The Scheduler I schedules all protocol‑required tasks for in‑life studies, ensuring proper placement of employees into specific study activities based on competency and responsibilities. Additionally, they schedule employee department and global trainings, and manage the department‑level study schedule and resources.

Plans, coordinates and documents resource availability for proposed and active studies. Coordinates with Client Services, Resource Management, Operations, supporting labs, and consultants to ensure accurate scheduling and logistics.

• Associate’s degree (A.A./A.S.) or equivalent in scientific support/administrative or related discipline.
• 2 years of related experience in a laboratory or research environment. Previous experience in a GLP environment preferred.
• An equivalent combination of education and experience may be accepted as a satisfactory substitute for the specific education and experience listed above.
• Ability to interact with all levels of staff and sponsors. Strong communication and interpersonal skills and attention to detail. Proficient in the use of word processing, spreadsheet and database desktop applications.
• The starting wage is $20.50 USD per hour. Please note that salaries vary within the range based on factors including, but not limited to, experience, skills, education, certifications, and location.
• Schedule is Monday‑Friday, 8 am – 5 pm daily.

Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state‑of‑the‑art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market.

Each year approximately 300 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.

Charles River is an early‑stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non‑GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients’ clinical laboratory testing needs and manufacturing activities.

Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.

With over 20,000 employees within 110 facilities in over 20 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client’s unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world.

At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well‑being of many across the globe. We have proudly worked on 80% of the drugs approved by the U.S. Food and…